Sphingotec’s Critical Care Biomarkers Early Diagnose Risk of Loss of Endothelial, Kidney and Heart Function in Severely Ill COVID-19 Patients
Results of a consensus meeting of clinical experts investigating sphingotec’s diagnostic solutions for acute and…